Imagion Biosystems Receives A$2.6 Million R&D Tax Incentive

Imagion Biosystems Limited is pleased to announce that it has received its 2020 R&D tax incentive claim of $2,612,159 from the Australian Taxation Office.

This is higher than the $2,197,028 received in respect of the 2019 claim and reflects increased R&D spend in 2020 as the Company undertook preparatory activities towards the first-in-human trial of its MagSense® imaging technology in HER2 positive breast cancer patients.

See the announcement.